| Field | Specification |
|---|---|
| Mfr No | |
| Concentration | |
| Form | dispersion |
| Molecular Weight | |
| Product Type | |
| Shipping | |
| Storage |
Overview
These embarked on recent developments in the preparation of IO nanoparticles by thermal decomposition method. We have significantly improved the quality of traditional iron oxide nanoparticles in terms of size tunability, monodispersity and crystalline structure.
Iron Oxide Nanoparticles in Chloroform have been coated with oleic acid for particle stability and the hydrophobic tail groups (hydrocarbon chains) of the oleic acid molecules line up to form a shell around the nanoparticle.
Key Features
- Narrow size distribution
- High crystallization
Applications
- As a liquid sealant in electronic devices
- As a nanolubricant in the aerospace industry
- As a catalyst
- As a refractor in many analytical instruments
- As an adaptive optics shape-shifting magnetic mirror for telescopes
- As a heat transfer device in loudspeakers to remove heat
Physical & Chemical Properties
- Chemical Stability: The product is chemically stable under standard ambient conditions (room temperature) .
- Solvent: chloroform
- Surface Group: oleic acid
These are superparamagnetic magnetite/maghemite nanoparticles (5–30 nm) prepared by thermal decomposition and coated with oleic acid. The hydrophobic oleic acid coating stabilizes the nanoparticles in organic solvents. Chloroform (25 mg/mL) is the standard dispersion solvent; the hydrophobic surface is incompatible with direct aqueous dispersion without ligand exchange.
Applications include use as ferrofluids in electronic devices, nanolubricants in the aerospace industry, catalysts, refractors in analytical instruments, adaptive optics shape-shifting magnetic mirrors for telescopes, and heat transfer devices in loudspeakers.
Yes — ligand exchange protocols can replace the oleic acid coating with hydrophilic ligands (e.g., DMSA, citrate, amphiphilic polymers) to transfer nanoparticles into aqueous buffers. Refer to the specification sheet for guidance. For pre-made aqueous iron oxide nanoparticles, see Iron Oxide Nanoparticles in Water or the functionalized nanoparticle series.
Available in 5, 10, 15, 20, 25, and 30 nm. Prepared by thermal decomposition, which produces narrow size distributions with high crystallinity — key advantages over co-precipitation methods for applications requiring monodisperse particles.
Chloroform is a hazardous solvent. Handle in a well-ventilated fume hood; use appropriate PPE. Do not freeze — store at 25°C per the product datasheet. Refer to the Safety Data Sheet (SDS) in the Documents section for full hazard, handling, and disposal information.
The following customization and add-on services are available for this product through the supplier. For inquiries and pricing, contact support@biohippo.com.
Customization Options
- Custom Nanoparticle Synthesis: Iron oxide nanoparticles with customized particle sizes (nanometers to micrometers), narrow size distributions, surface coatings, and functional groups can be synthesized for specialized imaging, drug delivery, or sensing applications.
- Custom Surface Modification: Deep understanding of surface chemistry allows custom modification of iron oxide nanoparticle surfaces for different applications — including custom PEG lengths, targeting ligands, or specific reactive groups.
- Custom Conjugation Service: Pre-conjugated iron oxide nanoparticle–antibody, nanoparticle–protein, or nanoparticle–drug conjugates can be prepared using your supplied biomolecule. The supplier specializes in conjugation chemistry across iron oxide nanoparticles, quantum dots, magnetic beads, and latex beads.
- Assay Development: Technical support for magnetic nanoparticle-based in vitro diagnostic assay development, including magnetic sensing assays and lateral flow platforms, is available.
- Bulk & OEM Manufacturing: Bulk iron oxide nanoparticle supply and OEM manufacturing for diagnostic and therapeutic research device development are available.
To inquire about customization options, request a quote, or discuss OEM manufacturing, contact support@biohippo.com.
- Amaolo A et al. (2026). Breaking Through the Barrier: Nanoparticle-Driven MRI Strategies for Diagnosis and Therapy of Pancreatic Cancer. ACS Nanosci Au. DOI: 10.1021/acsnanoscienceau.5c00116 PMID: 42004273
- Galarza-Arévalo GE et al. (2026). Clinical Applications and Future Prospects of Metallic Nanoparticles in Diagnosis and Therapy. Int J Nanomedicine. DOI: 10.2147/IJN.S567931 PMID: 42023082